Anti-IL22 (Fezakinumab)-SMCC-DM1 ADC
This ADC product is comprised of an anti-IL22 monoclonal antibody conjugated via a SMCC linker to DM1. The DM1 is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, DM1 binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
Product Specifications
CAS Number
9007-83-4
Format
Solution
Shipping Conditions
Ice Packs
Storage Conditions
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-7709R-BF350 100 µL
Retinoic acid induced 17 Antibody, AbBy Fluor™ 350 Conjugated
Sign In for Pricing
View Details